The synergism of co-mutated Npm1 and Flt3-ITD in AML tumorigenesis was further demonstrated in vivo and corresponded with a pronounced overall change in lymphoid progenitor cell gene expression (127, 128). The gene discussed is NPM1; the disease is acute myeloid leukemia.